The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol

Nature Medicine

Volumn 3, Issue 5, 1997, Pages 567-570

  Telenti, Amalio ^a,b   Philipp, Wolfgang J ^a   Sreevatsan, Srinand ^c   Bernasconi, Claudia ^a   Stockbauer, Kathryn E ^c   Wieles, Brigitte ^a   Musser, James M ^c   Jacobs Jr , William R ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; DRUG MECHANISM; GENE CLUSTER; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PROKARYOTA;

EID: 0030913996     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0597-567     Document Type: Article

References (30)

1. Takayama, K. & Kilburn, J.O. Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 33, 1493-1499 (1989).
2. Wolucka, B.A., McNeil, M.R., de Hoffmann, E., Chojnacki, T. & Brennan, P.J. Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria. J. Biol. Chem. 269, 23328-23335 (1994).
3. Bloch, A.B. et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 271, 665-671 (1994).
4. Belanger, A.E. et al. The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc. Natl. Acad. Sci. USA 93, 11919-11924 (1996).
5. Snapper, S.B., Melton, R.E., Mustafa, S., Kieser, T. & Jacobs, W.R., Jr. Isolation and characterization of efficient transformation mutants of Mycobacterium smegmatis. Mol. Microbiol. 4, 1911-1919 (1990).
6. Eiglmeier, K., Honoré, N., Woods, S.A., Caudron, B. & Cole, S.T. Use of an ordered library to deduce the genomic organization of Mycobacterium leprae. Mol. Microbiol. 7, 197-206 (1993).
7. Maddry, J.A., Suling, W.J. & Reynolds, R.C. Glycosyl transferases as targets for inhi-bition of cell wall synthesis in M. tuberculosis and M. avium. Res. Microblol. 147, 106-112 (1996).
8. Deng, L. et al. Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope. Antimicrob. Agents Chemother. 39, 694-701 (1995).
9. Musser, J.M. Antimicrobial agent resistance in mycobacteria: Molecular genetic insights. Clin. Microbiol. Rev. 8, 496-514 (1995).
10. Telenti, A. Genetics of drug resistance in tuberculosis. Clin. Chest Med. 18, 5.1-5.10 (1997).
11. Zhang, Y., Heym, B., Allen, B., Young, D. & Cole, ST. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358, 501-593 (1992).
12. Banerjee, A. et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263, 227-230 (1994).
13. Deretic, V. et al. Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: Implications for sensitivity to isoniazid. Mol. Microbiol. 17, 889-900 (1995).
14. Wilson, T.M. & Collins, D.M. ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. Mol. Microbiol. 19, 1025-1034 (1996).
15. Telenti, A. et al. Cenotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: A blind study at reference laboratory level. J. Clin. Microbiol. 35, 719-723 (1997).
16. Telenti, A. et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341, 647-650 (1993).
17. Finken, M., Kirschner, P., Meier, A., Wrede, A. & Bottger, E.C. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: Alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol. Microbiol. 9, 1239-1246 (1993).
18. Honoré, N. & Cole, ST. Streptomycin resistance in mycobacteria. Antimicrob. Agents Chemother. 38, 238-242 (1994).
19. Takiff, H.E. et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob. Agents Chemother. 38, 773-780 (1994).
20. Kocagoz, T. et al. Gyrase mutations in laboratory selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrob. Agents Chemother. 40, 1768-1774 (1996).
21. Takiff, H.E. et al. Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc. Natl. Acad. Sci. USA 93, 362-366 (1996).
22. Scorpio, A. & Zhang, Y. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nature Med. 2, 662-667 (1996).
23. Telenti, A. & Persing, D.H. Novel strategies for the detection of drug resistance in Mycobacterium tuberculosis. Res. Microbiol. 147, 73-79 (1996).
24. Lazlo, A., Rahman, M., Raviglione, M., Bustreo, F. & the WHO/IUTLD network of supranational reference laboratories. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUTLD supranational laboratory network: First round of proficiency testing. Intl. J. Tuberculosis Lung Dis. (in the press).
25. Gangadharam, P.R. & Gonzalez, E.R. Influence of the medium on the in vitro susceptibility of Mycobacterium tuberculosis to ethambutol. Am. Rev. Resp. Dis. 102, 653-655 (1970).
26. Heifets, L.B., Iseman, M.D. & Lindholm-Levy, P. J. Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 30, 927-932 (1986).
27. Levin, M.E. & Hatfull, G.F. Mycobacterium smegmatis RNA polymerase: DNA supercoiling, action of rifampicin and mechanism of rifampicin resistance. Mol. Microbiol. 8, 277-285 (1993).
28. Rost, B. & Sander, C. Combining evolutionary information and neural networks to predict protein secondary structure. Proteins 19, 55-72 (1994).
29. Philipp, W.J. et al. An integrated map of the genome of the tubercle bacillus, Mycobacterium tuberculosis H37Rv, and comparison with M. leprae. Proc. Natl. Acad. Sci. USA 93, 3132-3137 (1996).
30. Telenti, A., Imboden, P., Marchesi, F., Schmidheini, T. & Bodmer, T. Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism. Antimicrob. Agents Chemother. 37, 2054-2058 (1993).